Trial Profile
A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Nateglinide (Primary) ; Glibenclamide
- Indications Diabetic nephropathies; Proteinuria; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novartis
- 03 May 2012 New trial record